Profiling of 3D Genome Organization in Nasopharyngeal Cancer Needle Biopsy Patient Samples by a Modified Hi-C Approach
Overview
Authors
Affiliations
Nasopharyngeal cancer (NPC), a cancer derived from epithelial cells in the nasopharynx, is a cancer common in China, Southeast Asia, and Africa. The three-dimensional (3D) genome organization of nasopharyngeal cancer is poorly understood. A major challenge in understanding the 3D genome organization of cancer samples is the lack of a method for the characterization of chromatin interactions in solid cancer needle biopsy samples. Here, we developed Biop-C, a modified Hi-C method using solid cancer needle biopsy samples. We applied Biop-C to characterize three nasopharyngeal cancer solid cancer needle biopsy patient samples. We identified topologically associated domains (TADs), chromatin interaction loops, and frequently interacting regions (FIREs) at key oncogenes in nasopharyngeal cancer from the Biop-C heatmaps. We observed that the genomic features are shared at some important oncogenes, but the patients also display extensive heterogeneity at certain genomic loci. On analyzing the super enhancer landscape in nasopharyngeal cancer cell lines, we found that the super enhancers are associated with FIREs and can be linked to distal genes chromatin loops in NPC. Taken together, our results demonstrate the utility of our Biop-C method in investigating 3D genome organization in solid cancers.
Mao R, Cai Z, Wang T, Li Y, Tian S, Li D Front Genet. 2024; 15:1480153.
PMID: 39634272 PMC: 11615058. DOI: 10.3389/fgene.2024.1480153.
Zhao S, Bootsma M, Zhou S, Shrestha R, Moreno-Rodriguez T, Lundberg A Nat Genet. 2024; 56(8):1689-1700.
PMID: 39020220 PMC: 11319208. DOI: 10.1038/s41588-024-01826-3.
Stephenson-Gussinye A, Furlan-Magaril M Front Cell Dev Biol. 2023; 11:1219968.
PMID: 37457299 PMC: 10346842. DOI: 10.3389/fcell.2023.1219968.
Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer.
Tang S, Vijayakumar U, Zhang Y, Fullwood M Cancers (Basel). 2022; 14(12).
PMID: 35740532 PMC: 9221043. DOI: 10.3390/cancers14122866.